Detalhe da pesquisa
1.
Impact of body mass index on pathological response after neoadjuvant chemotherapy: results from the I-SPY 2 trial.
Breast Cancer Res Treat
; 204(3): 589-597, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38216819
2.
Patient perspectives on window of opportunity clinical trials in early-stage breast cancer.
Breast Cancer Res Treat
; 194(1): 171-178, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35538268
3.
The WISDOM study: a new approach to screening can and should be tested.
Breast Cancer Res Treat
; 189(3): 593-598, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34529196
4.
18F-FDG Dedicated Breast PET Complementary to Breast MRI for Evaluating Early Response to Neoadjuvant Chemotherapy.
Radiol Imaging Cancer
; 6(2): e230082, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38551406
5.
Impact of Body Mass Index on Pathological Response after Neoadjuvant Chemotherapy: Results from the I-SPY 2 trial.
Res Sq
; 2023 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37397981
6.
Rationale, Study Design, and Cohort Characteristics for the Markers for Environmental Exposures (MEE) Study.
Int J Environ Res Public Health
; 17(5)2020 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32182891